A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review

According to a story from Morningstar, the company Alexion Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review their Biologics Licensing Application for their…

Continue Reading A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review
So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
FrankWinkler / Pixabay

So Why DOES Canada have Scarcer Access to Rare Disease Therapies?

According to a story from CheckOrphan, Durhane Wong-Rieger, the CEO of the Canadian Organization for Rare Disorders, says that the Canadian health system has been letting down the roughly three…

Continue Reading So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
12019 / Pixabay

Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors

  The survival rates for infants and children with brain and spinal cord cancer has improved significantly over the past decades. However, a study published online in early August of…

Continue Reading Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
Aplastic Anemia and MDS International Foundation: 2018 Scientific Symposium
Hans / Pixabay

Aplastic Anemia and MDS International Foundation: 2018 Scientific Symposium

At the 2018 Aplastic Anemia and MDS International Foundation’s (AAMDSIF) International Bone Marrow Failure Disease Scientific Symposium of March 2018, Dr. David Margolis from the Medical College of Wisconsin, and…

Continue Reading Aplastic Anemia and MDS International Foundation: 2018 Scientific Symposium

New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia

According to a story from the FH Foundation, the non-profit organization has released a vital consensus statement regarding the diagnosis of familial hypercholesterolemia, which is the most prevalent genetic cause…

Continue Reading New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia
A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment
https://pixabay.com/en/clock-time-watch-hours-minutes-407101/

A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment

According to a story from cbc.ca, Cole Pringle is a 31-year-old man from Regina, Saskatchewan with spinal muscular atrophy, a debilitating illness that severely affects his mobility. He was diagnosed…

Continue Reading A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment